Resolution of invasive central nervous system aspergillosis in a transplant recipient

Bone Marrow Transplantation

Volumn 20, Issue 2, 1997, Pages 179-180

  Khoury, H ^a   Adkins, D ^a   Miller, G ^a   Goodnough, L ^a   Brown, R ^a   DiPersio, J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphotericin B; Aspergillus; Brain; Marrow transplantation

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT;

ADOLESCENT; ARTICLE; ASPERGILLOSIS; BONE MARROW TRANSPLANTATION; BRAIN BIOPSY; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; DRUG EFFICACY; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030835275     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700852     Document Type: Article

References (5)

1. Hiemenz JW, Walsh TJ. Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis 1996; 22: S133-S144.
2. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: Review of 2121 published cases. Rev Infect Dis 1990; 12: 1147-1201.
3. Coleman JM, Hogg GG, Rosenfeld JV, Waters KD. Invasive central nervous system aspergillosis: Cure with liposomal amphotericin B. Itraconazole, and radical surgery case report and review of the literature. Neurosurgery 1995; 36: 858-863.
4. Sharkey PK, Graybill JR, Johnson ES. Amphotericin B lipid complex compared to amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1996; 22: 315-321.
5. Moss RL, Das JB, Raffensperger JG. Total parenteral nutrition-associated cholestasis: clinical and histopathologic correlation. J Pediatr Surg 1993; 28: 1270-1275.